Capsaicin (Propella Therapeutics)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug NameCapsaicin (Propella Therapeutics)
Drug Alias NameASKC200ASKC-200CGS-200-5CGS-125CGS-200-1 +[6] 
ClassificationSmall molecules
Mechanisms of ActionVanilloid receptor agonists
TargetsTransient receptor potential cation channel subfamily V member 1
Therapy Area/IndicationsPainOsteoarthritis, KneeOsteoarthritis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesPropella Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesFrontage Laboratories IncPropella Therapeutics IncJiangsu Aosaikang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPainOsteoarthritis, KneeOsteoarthritis +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A